Additional Files

Vainshelboim, B., & Myers, J. (2021). Resistance Training for Rehabilitation in Patients with Idiopathic Pulmonary Fibrosis. Translational Medicine and Exercise Prescription, 1(1), 62–69. https://doi.org/10.53941/tmep.v1i1.34

Resistance Training for Rehabilitation in Patients with Idiopathic Pulmonary Fibrosis

Baruch Vainshelboim()1 and Jonathan Myers2 

1Cardiovascular and Metabolic Disease Research Institute, Mountain View, CA, USA

2Cardiology Division, Veterans Affairs Palo Alto Health Care System / Stanford University, Palo Alto, CA, USA

© The Authors


 

Abstract

Idiopathic pulmonary fibrosis (IPF) is a debilitating condition that causes severe symptoms, impaired functional capacity and poor quality of life. Exercise training has been shown to be a safe and effective therapy for improving physical function, dyspnea and quality of life in patients with IPF. However, due to pathophysiological limitations and symptom burden, conducting safe and effective exercise interventions is challenging; optimal program components and training modalities are yet to be established. Resistance training (RT) is a well-established exercise modality for combating effects of aging, disuse and chronic diseases, although there are scarce data available among patients with IPF. The current review briefly summarizes the pathophysiology and clinical manifestations of IPF and describes the numerous health and clinical benefits of RT among older adults and patients with respiratory disease. It then explores the potential RT mechanisms for overcoming exercise limitations in IPF, which may provide a therapeutic opportunity for rehabilitation. Finally, the review suggests practical RT recommendations for pulmonary rehabilitation programs in patients with IPF.

muscle strength functional capacity activity of daily living physical performance

References

  1. Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 2011,183:788-24. https://doi.org/10.1164/rccm.2009-040GL
  2. Olson AL, Swigris JJ, Lezotte DC, Norris JM, Wilson CG, Brown KK. Mortality from pulmonary fibrosis increased in the United States from 1992 to 2003. Am J Respir Crit Care Med 2007,176:277-84. https://doi.org/10.1164/rccm.200701-044OC
  3. Meltzer EB, Noble PW. Idiopathic pulmonary fibrosis. Orphanet J Rare Dis 2008,3:8.
  4. Swigris JJ, Brown KK, Make BJ, Wamboldt FS. Pulmonary rehabilitation in idiopathic pulmonary fibrosis: a call for continued investigation. Respir Med 2008,102:1675-80. https://doi.org/10.1016/j.rmed.2008.08.014
  5. American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement. American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am J Respir Crit Care Med 2000,161:646-64. https://doi.org/10.1164/ajrccm.161.2.ats3-00
  6. Swigris JJ, Kuschner WG, Jacobs SS, Wilson SR, Gould MK. Health-related quality of life in patients with idiopathic pulmonary fibrosis: a systematic review. Thorax 2005,60:588-94. https://doi.org/10.1136/thx.2004.035220
  7. Raghu G, Remy-Jardin M, Myers JL, Richeldi L, Ryerson CJ, Lederer DJ, et al. Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline. Am J Respir Crit Care Med 2018,198:e44-68. https://doi.org/10.1164/rccm.201807-1255ST
  8. King TE, Bradford WZ Jr, Castro-Bernardini S, Fagan EA, Glaspole I, Glassberg MK, et al. A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. New Engl J Med 2014,370:2083-92. https://doi.org/10.1056/NEJMoa1402582
  9. Noble PW, Albera C, Bradford WZ, Costabel U, Glassberg MK, Kardatzke D, et al. Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials. Lancet 2011,377:1760-69. https://doi.org/10.1016/S0140-6736(11)60405-4
  10. Richeldi L, du Bois RM, Raghu G, Azuma A, Brown KK, Costabel U, et al. Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. New Engl J Med 2014,370:2071-82. https://doi.org/10.1056/NEJMoa1402584
  11. Canestaro WJ, Forrester SH, Raghu G, Ho L, Devine BE. Drug treatment of idiopathic pulmonary fibrosis: systematic review and network meta-analysis. Chest 2016,149:756-66. https://doi.org/10.1016/j.chest.2015.11.013
  12. Cheng L, Tan B, Yin Y, Wang S, Jia L, Warner G, et al. Short- and long-term effects of pulmonary rehabilitation for idiopathic pulmonary fibrosis: a systematic review and meta-analysis. Clin Rehabil 2018,32:1299-307. https://doi.org/10.1177/0269215518779122
  13. Dowman L, Hill CJ, Holland AE. Pulmonary rehabilitation for interstitial lung disease. Cochrane Database Syst Rev 2014,10:CD006322. https://doi.org/10.1002/14651858.CD006322.pub3
  14. Dowman LM, McDonald CF, Hill CJ, Lee AL, Barker K, Boote C, et al. The evidence of benefits of exercise training in interstitial lung disease: a randomised controlled trial. Thorax 2017,72:610-19. https://doi.org/10.1136/thoraxjnl-2016-208638
  15. Gomes-Neto M, Silva CM, Ezequiel D, Conceicao CS, Saquetto M, Machado AS. Impact of pulmonary rehabilitation on exercise tolerance and quality of life in patients with idiopathic pulmonary fibrosis: a systematic review and meta-analysis. J Cardiopulm Rehabil Prev 2018,38:273-78. https://doi.org/10.1097/HCR.0000000000000273
  16. Holland A, Hill C. Physical training for interstitial lung disease. Cochrane Database Syst Rev 2008:CD006322. https://doi.org/10.1002/14651858.CD006322.pub2
  17. Jackson RM, Gomez-Marin OW, Ramos CF, Sol CM, Cohen MI, Gaunaurd IA, et al. Exercise limitation in IPF patients: a randomized trial of pulmonary rehabilitation. Lung 2014. https://doi.org/10.1007/s00408-014-9566-9
  18. Nishiyama O, Kondoh Y, Kimura T, Kato K, Kataoka K, Ogawa T, et al. Effects of pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis. Respirology 2008,13:394-99. https://doi.org/10.1111/j.1440-1843.2007.01205.x
  19. Vainshelboim B, Oliveira J, Yehoshua L, Weiss I, Fox BD, Fruchter O, et al. Exercise training-based pulmonary rehabilitation program is clinically beneficial for idiopathic pulmonary fibrosis. Respiration 2014,88:378-88. https://doi.org/10.1159/000367899
  20. Yu X, Li X, Wang L, Liu R, Xie Y, Li S, et al. Pulmonary rehabilitation for exercise tolerance and quality of life in IPF patients: a systematic review and meta-analysis. Biomed Res Int 2019,2019:8498603. https://doi.org/10.1155/2019/8498603
  21. Holland AE, Hill CJ, Conron M, Munro P, McDonald CF. Short term improvement in exercise capacity and symptoms following exercise training in interstitial lung disease. Thorax 2008,63:549-54. https://doi.org/10.1136/thx.2007.088070
  22. Vainshelboim B. Clinical improvement and effectiveness of exercise-based pulmo- nary rehabilitation in patients with idiopathic pulmonary fibrosis: a brief analytical review. J Cardiopulm Rehabil Prev 2020. https://doi.org/10.1097/HCR.0000000000000544
  23. Vainshelboim B. Exercise training in idiopathic pulmonary fibrosis: is it of benefit? Breathe (Sheff) 2016,12:130-38. https://doi.org/10.1183/20734735.006916
  24. Vainshelboim B, Fox BD, Oliveira J, Kramer MR. Exercise training in id- iopathic pulmonary fibrosis. Expert Rev Respir Med 2016,10:69-77. https://doi.org/10.1586/17476348.2016.1121104
  25. Fragala MS, Cadore EL, Dorgo S, Izquierdo M, Kraemer WJ, Peterson MD, et al. Resistance training for older adults: position statement from the national strength and conditioning association. J Strength Cond Res 2019,33:2019-52. https://doi.org/10.1519/JSC.0000000000003230
  26. American College of Sports Medicine position stand. Progression models in re- sistance training for healthy adults. Med Sci Sports Exerc 2009,41:687-708. https://doi.org/10.1249/MSS.0b013e3181915670
  27. Fukuda Y, Basset F, Ferrans VJ, Yamanaka N. Significance of early intra-alveolar fibrotic lesions and integrin expression in lung biopsy specimens from patients with idiopathic pulmonary fibrosis. Hum Pathol 1995,26:53-61. https://doi.org/10.1016/0046- 8177(95)90114-0
  28. Holland AE. Exercise limitation in interstitial lung disease - mechanisms, sig- nificance and therapeutic options. Chron Respir Dis 2010,7:101-11. https://doi.org/10.1177/1479972309354689
  29. Lama VN, Martinez FJ. Resting and exercise physiology in interstitial lung diseases. Clin Chest Med 2004,25:435-53, v. https://doi.org/10.1016/j.ccm.2004.05.005
  30. Spruit MA, Singh SJ, Garvey C, Zuwallack R, Nici L, Rochester C, et al. An official american thoracic society/european respiratory society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med 2013,188:e13-64. https://doi.org/10.1164/rccm.201309-1634ST
  31. Fell CD, Liu LX, Motika C, Kazerooni EA, Gross BH, Travis WD, et al. The prog- nostic value of cardiopulmonary exercise testing in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2009,179:402-07. https://doi.org/10.1164/rccm.200802-241OC
  32. Layton AM, Armstrong HF, Kim HP, Meza KS, D'Ovidio F, Arcasoy SM. Cardiopul- monary exercise factors predict survival in patients with advanced interstitial lung disease referred for lung transplantation. Respir Med 2017,126:59-67. https://doi.org/10.1016/ j.rmed.2017.03.022
  33. Triantafillidou C, Manali E, Lyberopoulos P, Kolilekas L, Kagouridis K, Gyftopou- los S, et al. The role of cardiopulmonary exercise test in IPF prognosis. Pulm Med 2013,2013:514817. https://doi.org/10.1155/2013/514817
  34. Vainshelboim B, Oliveira J, Fox BD, Kramer MR. The prognostic role of ventilatory inefficiency and exercise capacity in idiopathic pulmonary fibrosis. Respir Care 2016,61:1100-109. https://doi.org/10.4187/respcare.04471
  35. Vainshelboim B, Oliveira J, Fox BD, Adir Y, Ollech JE, Kramer MR. Physiological profile and limitations in exercise in idiopathic pulmonary fibrosis. J Cardiopulm Rehabil Prev 2016. https://doi.org/10.1097/HCR.0000000000000177
  36. Lama VN, Flaherty KR, Toews GB, Colby TV, Travis WD, Long Q, et al. Prognostic value of desaturation during a 6-minute walk test in idiopathic interstitial pneumonia. Am J Respir Crit Care Med 2003,168:1084-90. https://doi.org/10.1164/rccm.200302-219OC
  37. Vainshelboim B, Kramer MR, Izhakian S, Lima RM, Oliveira J. Physical activity and exertional desaturation are associated with mortality in idiopathic pulmonary fibrosis. J Clin Med 2016,5. https://doi.org/10.3390/jcm5080073
  38. Ryerson CJ, Donesky D, Pantilat SZ, Collard HR. Dyspnea in idiopathic pulmo- nary fibrosis: a systematic review. J Pain Symptom Manag 2012,43:771-82. https://doi.org/10.1016/j.jpainsymman.2011.04.026
  39. Mura M, Porretta MA, Bargagli E, Sergiacomi G, Zompatori M, Sverzellati N, et al. Predicting survival in newly diagnosed idiopathic pulmonary fibrosis: a 3-year pro- spective study. Eur Respir J 2012,40:101-09. https://doi.org/10.1183/09031936.00106011
  40. Kozu R, Jenkins S, Senjyu H. Effect of disability level on response to pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis. Respirology 2011,16:1196-202. https://doi.org/10.1111/j.1440-1843.2011.02029.x
  41. Spruit MA, Wouters EF. New modalities of pulmonary rehabilitation in patients with chronic obstructive pulmonary disease. Sports Med 2007,37:501-18. https://doi.org/10.2165/00007256-200737060-00004
  42. Wallaert B, Monge E, Le Rouzic O, Wemeau-Stervinou L, Salleron J, Grosbois JM. Physical activity in daily life of patients with fibrotic idiopathic interstitial pneumonia. Chest 2013,144:1652-58. https://doi.org/10.1378/chest.13-0806
  43. Atkins C, Baxter M, Jones A, Wilson A. Measuring sedentary behaviors in patients with idiopathic pulmonary fibrosis using wrist-worn accelerometers. Clin Respir 2016. https://doi.org/10.1111/crj.12589
  44. Leuchte HH, Mernitz P, Baezner C, Baumgartner RA, von Wulffen W, Neurohr C, et al. Self-report daily life activity as a prognostic marker of idiopathic pulmonary fibrosis. Respiration 2015,90:460-67. https://doi.org/10.1159/000441302
  45. Vainshelboim B, Oliveira J, Izhakian S, Unterman A, Kramer MR. Lifestyle behaviors and clinical outcomes in idiopathic pulmonary fibrosis. Respiration 2018,95:27-34. https://doi.org/10.1159/000481202
  46. Garber CE, Blissmer B, Deschenes MR, Franklin BA, Lamonte MJ, Lee IM, et al. American College of Sports Medicine position stand. Quantity and quality of exercise for developing and maintaining cardiorespiratory, musculoskeletal, and neuromotor fitness in apparently healthy adults: guidance for prescribing exercise. Med Sci Sports Exerc 2011,43:1334-59. https://doi.org/10.1249/MSS.0b013e318213fefb
  47. Chodzko-Zajko WJ, Proctor DN, Fiatarone Singh MA, Minson CT, Nigg CR, Salem GJ, et al. American College of Sports Medicine position stand. Exercise and physical activity for older adults. Med Sci Sports Exerc 2009,41:1510-30. https://doi.org/10.1249/MSS.0b013e3181a0c95c
  48. Garcia-Hermoso A, Cavero-Redondo I, Ramirez-Velez R, Ruiz JR, Ortega FB, Lee DC, et al. Muscular strength as a predictor of all-cause mortality in an apparently healthy population: a systematic review and meta-analysis of data from approximately 2 million men and women. Arch Phys Med Rehabil 2018,99:2100-13 e5. https://doi.org/10.1016/j.apmr.2018.01.008
  49. Li R, Xia J, Zhang XI, Gathirua-Mwangi WG, Guo J, Li Y, et al. Associations of muscle mass and strength with all-cause mortality among US older adults. Med Sci Sports Exerc 2018,50:458-67. https://doi.org/10.1249/MSS.0000000000001448
  50. Volaklis KA, Halle M, Meisinger C. Muscular strength as a strong predictor of mortality: A narrative review. Eur J Intern Med 2015,26:303-10. https://doi.org/10.1016/j.ejim.2015.04.013
  51. Biswas A, Oh PI, Faulkner GE, Bajaj RR, Silver MA, Mitchell MS, et al. Sedentary time and its association with risk for disease incidence, mortality, and hospitalization in adults: a systematic review and meta-analysis. Ann Intern Med 2015,162:123-32. https://doi.org/10.7326/M14-1651
  52. De Rezende LF, Rodrigues Lopes M, Rey-Lopez JP, Matsudo VK, Luiz Odo C. Sedentary behavior and health outcomes: an overview of systematic reviews. PLoS One 2014,9:e105620. https://doi.org/10.1371/journal.pone.0105620
  53. Keadle SK, Conroy DE, Buman MP, Dunstan DW, Matthews CE. Targeting reductions in sitting time to increase physical activity and improve health. Med Sci Sports Exerc 2017,49:1572-82. https://doi.org/10.1249/MSS.0000000000001257
  54. Thyfault JP, Du M, Kraus WE, Levine JA, Booth FW. Physiology of sedentary behavior and its relationship to health outcomes. Med Sci Sports Exerc 2015,47:1301-305. https://doi.org/10.1249/MSS.0000000000000518
  55. Patterson R, McNamara E, Tainio M, de Sa TH, Smith AD, Sharp SJ, et al. Sedentary behaviour and risk of all-cause, cardiovascular and cancer mortality, and incident type 2 diabetes: a systematic review and dose response meta-analysis. Eur J Epidemiol 2018,33:811-29. https://doi.org/10.1007/s10654-018-0380-1
  56. Vainshelboim B, Oliveira J, Fox BD, Adir Y, Ollech JE, Kramer MR. Physiological profile and limitations in exercise in idiopathic pulmonary fibrosis. J Cardiopulm Rehabil Prev 2016,36:270-28. https://doi.org/10.1097/HCR.0000000000000177
  57. Vainshelboim B, Kramer MR, Myers J, Unterman A, Izhakian S, Oliveira J. 8-footup-and-go test is associated with hospitalizations and mortality in idiopathic pulmonary fibrosis: a prospective pilot study. Lung 2019,197:81-88. https://doi.org/10.1007/s00408-018-0189-4
  58. Hurley BF, Hanson ED, Sheaff AK. Strength training as a countermeasure to aging muscle and chronic disease. Sports Med 2011,41:289-306. https://doi.org/10.2165/11585920-000000000-00000
  59. McLeod JC, Stokes T, Phillips SM. Resistance exercise training as a primary countermeasure to age-related chronic disease. Front Physiol 2019,10:645. https://doi.org/10.3389/fphys
  60. Westcott WL. Resistance training is medicine: effects of strength training on health. Curr Sports Med Reports 2012,11:209-16. https://doi.org/10.1249/JSR
  61. Saeidifard F, Medina-Inojosa JR, West CP, Olson TP, Somers VK, Bonikowske AR, et al. The association of resistance training with mortality: A systematic review and meta-analysis. Europ J Prev Cardiol 2019,26:1647-65. https://doi.org/10.1177/2047487319850718
  62. Shiroma EJ, Cook NR, Manson JE, Moorthy MV, Buring JE, Rimm EB, et al. Strength training and the risk of type 2 diabetes and cardiovascular disease. Med Sci Sports Exerc 2017,49:40-46. https://doi.org/10.1249/MSS.0000000000001063
  63. Ashton RE, Tew GA, Aning JJ, Gilbert SE, Lewis L, Saxton JM. Effects of shortterm, medium-term and long-term resistance exercise training on cardiometabolic health outcomes in adults: systematic review with meta-analysis. Br J Sports Med 2020,54:341-48. https://doi.org/10.1136/bjsports-2017-098970
  64. Stamatakis E, Lee IM, Bennie J, Freeston J, Hamer M, O'Donovan G, et al. Does strength-promoting exercise confer unique health benefits? a pooled analysis of data on 11 population cohorts with all-cause, cancer, and cardiovascular mortality endpoints. Am J Epidemiol 2018,187:1102-12. https://doi.org/10.1093/aje/kwx345
  65. Kraschnewski JL, Sciamanna CN, Poger JM, Rovniak LS, Lehman EB, Cooper AB, et al. Is strength training associated with mortality benefits? A 15 year cohort study of US older adults. Prev Med 2016,87:121-27. https://doi.org/10.1016/j.ypmed
  66. Hardee JP, Porter RR, Sui X, Archer E, Lee IM, Lavie CJ, et al. The effect of resistance exercise on all-cause mortality in cancer survivors. Mayo Clin Proc 2014,89:1108-15. https://doi.org/10.1016/j.mayocp
  67. Mazzilli KM, Matthews CE, Salerno EA, Moore SC. Weight training and risk of 10 common types of cancer. Med Sci Sports Exerc 2019,51:1845-51. https://doi.org/10.1249/MSS.0000000000001987
  68. Sherrington C, Fairhall N, Wallbank G, Tiedemann A, Michaleff ZA, Howard K, et al. Exercise for preventing falls in older people living in the community: an abridged Cochrane systematic review. Br J Sports Med 2020,54:885-91. https://doi.org/10.1136/bjsports-2019-101512
  69. Sherrington C, Michaleff ZA, Fairhall N, Paul SS, Tiedemann A, Whitney J, et al. Exercise to prevent falls in older adults: an updated systematic review and meta-analysis. Br J Sports Med 2017,51:1750-58. https://doi.org/10.1136/bjsports-2016-096547
  70. Sherrington C, Whitney JC, Lord SR, Herbert RD, Cumming RG, Close JC. Effective exercise for the prevention of falls: a systematic review and meta-analysis. J Am Geriatr Soc 2008,56:2234-43. https://doi.org/10.1111/j.1532-5415.2008.02014.x
  71. Borde R, Hortobagyi T, Granacher U. Dose-response relationships of resistance training in healthy old adults: a systematic review and meta-analysis. Sports Med 2015,45:1693-720. https://doi.org/10.1007/s40279-015-0385-9
  72. Moreland JD, Richardson JA, Goldsmith CH, Clase CM. Muscle weakness and falls in older adults: a systematic review and meta-analysis. J Am Geriatr Soc 2004,52:1121-29. https://doi.org/10.1111/j.1532-5415.2004.52310.x
  73. Erickson KI, Hillman C, Stillman CM, Ballard RM, Bloodgood B, Conroy DE, et al. Physical activity, cognition, and brain outcomes: a review of the 2018 physical activity guidelines. Med Sci Sports Exerc 2019,51:1242-51. https://doi.org/10.1249/MSS.0000000000001936
  74. Beydoun MA, Beydoun HA, Gamaldo AA, Teel A, Zonderman AB, Wang Y. Epidemiologic studies of modifiable factors associated with cognition and dementia: systematic review and meta-analysis. BMC Public Health 2014,14:643. https://doi.org/10.1186/1471-2458-14-643
  75. Northey JM, Cherbuin N, Pumpa KL, Smee DJ, Rattray B. Exercise interventions for cognitive function in adults older than 50: a systematic review with meta-analysis. Br J Sports Med 2018,52:154-60. https://doi.org/10.1136/bjsports-2016-096587
  76. Vaportzis E, Niechcial MA, Gow AJ. A systematic literature review and meta-analysis of real-world interventions for cognitive ageing in healthy older adults. Ageing Res Rev 2019,50:110-30. https://doi.org/10.1016/j.arr.2019.01.006
  77. O'Shea SD, Taylor NF, Paratz JD. Progressive resistance exercise improves muscle strength and may improve elements of performance of daily activities for people with COPD: a systematic review. Chest 2009,136:1269-83. https://doi.org/10.1378/chest.09-0029
  78. Liao WH, Chen JW, Chen X, Lin L, Yan HY, Zhou YQ, et al. Impact of resistance training in subjects with COPD: a systematic review and meta-analysis. Respir Care 2015,60:1130-45. https://doi.org/10.4187/respcare
  79. Arizono S, Taniguchi H, Sakamoto K, Kondoh Y, Kimura T, Kataoka K, et al. Endurance time is the most responsive exercise measurement in idiopathic pulmonary fibrosis. Respir Care 2014,59:1108-15. https://doi.org/10.4187/respcare.02674